EPL Archives

Your Trusted Biorepository

Can a single vendor provide global managed biorepository services and solutions that biopharmaceutical, research, and manufacturing organizations need?  More than 95% of the Fortune 50 pharmaceutical and biotechnology companies agree: when you choose EPL Archive’s (EPL) Biorepository Services and Solutions – the answer is yes.

Biopharmaceutical research, development and manufacturing activities generate tremendous operational, financial and legal value.  Along with that comes complexity, additional costs, and the additional risks associated with global biomaterials management.  EPL’s biorepository services and solutions provide complete visibility, protection and secure access to all your biomaterials using consistent compliant procedures.

Compliant Storage – Secure Access – Global Management.

We understand the complex processes used by companies involved in biopharmaceutical research, development and manufacturing activities.  We also understand the high costs and risks associated with in-house global biomaterials management.  Our services can help you more effectively manage these assets and are available for purchase separately or as an integrated solution.

  • Managed biorepository services reduce your costs, risks, and complexity by using our professional biomaterials management services – from creation to disposal and everything in between, including: logistics; indexing; processing; storage; escrow; verification; and format conversion throughout their lifecycle.
  • Strategic biorepository solutions utilize EPL’s industry leading expertise and experience to: assess risks; create compliant biobanking/storage/archive programs; manage on-site repositories; collaborate on facility designs; get assurance through our independent audits and more.
  • Consulting and special projects address unique one-time, short-term or ongoing biorepository program needs with a trusted partner that has over three decades of past performance qualifications and an outstanding industry reputation.  A partner who understands the meaning of compliance and how to reduce cost, risk and complexity for companies, universities and governments that support the discovery, pre-clinical, clinical, and manufacturing phases of biopharmaceuticals development.  Examples include facility shutdowns and relocations, master index (MI) reconciliation, temporary or permanent staffing and custom biomaterials tracking systems.

Contact us today to discuss how you can:

  • Maximize the quality and extend the life of your ongoing research, development and manufacturing investments.
  • Reduce pipeline risk by consolidating scattered global biomaterials into highly visible and accessible strategic assets.
  • Reduce your biostorage costs by 25-50% and focus on your core competencies.
  • Improve and manage global regulatory compliance over time.